Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
Page 1
| Issued: 2 August 2007 at 10:00 |
Ref: MDA/2007/059
|
|
|
Immediate action |
|
Action |
|
|
Update |
|
|
Information request |
| Device: Point of care blood glucose measurement systems: HemoCue Glucose 201+ and HemoCue Glucose 201 RT. |
|||||
| Problem: Potential for false zero readings of blood glucose concentration. |
>Page 2 |
||||
| Action by: All staff treating patients based on results from these devices. Healthcare personnel procuring, using or managing these devices. |
|||||
|
Action:
|
|||||
|
Distributed to:
* via CE Bulletin |
>Page 2 |
||||
| Contacts: Details of manufacturer contacts and MHRA contacts for technical and clinical aspects. Change of address or removal from address list for Healthcare Commission. |
>Pages 2-3 |
||||
| Appendix: Manufacturer field safety notice re-issued on 25/06/07. |
>Page 4 |
|
Action deadlines for the Safety Alert Broadcast System (SABS)
|
|
|
Deadline (action underway): 09 August 2007
|
Deadline (action complete): 06 September 2007
|
MDA/2007/059 - Point of care blood glucose measurement systems: HemoCue Glucose 201+ and HemoCue Glucose 201 RT 
